Donate Join Us

Day 2 Encephalitis Conference 2024 (Tuesday 3rd December)

 

KEYNOTE SPEAKERS

Professor Michael Wilson, UCSF Weill Institute for Neurosciences, USA

“Metagenomics, Encephalitis and Global Health”

Dr Marianna Spatola, University of Barcelona and La Caixa Research Institute, Spain

“Functional Effects of Antibodies in Infectious and Autoimmune Encephalitis”

 

GUEST SPEAKERS:

Dr Ava Easton, Encephalitis International & University of Liverpool, UK

“Brains on Fire: Patient Outcomes and Quality of Life Following Encephalitis”

Dr Bhagteshwar Singh, University of Liverpool & Royal Liverpool University Hospital, UK

“Improving Diagnosis and Management of People with Brain Infections in Brazil, India and Malawi”


8:30 Registration

9:00 Welcome/Introduction

Dr Nicholas Davies, Chair Advisory Scientific Panel, Encephalitis International

Dr Ava Easton, CEO Encephalitis International & University of Liverpool

Session 1:

Chairs: Prof Carsten Finke, Charite – Universitatsmedizin Berlin, Germany. Dr James Sejvar, University of Pittsburgh, USA

9:05 KEYNOTE LECTURE 1

Functional Effects of Antibodies in Infectious and Autoimmune Encephalitis

Dr Marianna Spatola IDIBAPS Research Institute, University of Barcelona and La Caixa Research Institute, Barcelona, Spain; Hospital of Sion, Switzerland

9:30 Discussion

9:35 DPPX autoantibodies reduce A-type potassium currents and increase excitability in hippocampal neurons

Dr Sarah Crisp, University of Cambridge, UK

9:45 Discussion

9:50 An international validation of the SEIZURE score for predicting acute seizure risk in encephalitis

Dr Thomas Hughes, University of Liverpool, UK

10:00 Discussion

10:05 Brain atrophy in patients with anti-NMDA receptor encephalitis

Ms Hannah Tenenbaum, Charite – Universitatsmedizin Berlin, Germany

10:15 Discussion

10:20 Validation of the encephalitis criteria in patients with a suspected central nervous system infection: an updated score

Dr Steven L. Staal, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

10:30 Discussion

10:35 Psychiatric manifestations of encephalitis

Dr Ralph Habis, Johns Hopkins University School of Medicine, USA

10:45 Discussion

10:50 TEA/COFFEE/POSTER VIEWING

Session 2:

Chairs: Dr Nicholas Davies, Chelsea and Westminster, Charing Cross, and the Royal Marsden Hospitals, London, UK. Prof Arun Venkatesan, Johns Hopkins University School of Medicine, USA

11:10 Early corticosteroid treatment appears to improve the outcome of HSV encephalitis

Professor Tom Solomon, CBE, The Pandemic Institute; National Institute for Health and Care Research Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, UK

11:20 Discussion

11:25 Glycine-receptor antibody mediated CNS effects in vivo: a preliminary study

Dr Manoj Upadhya, Institute of Health and Neurodevelopment, Aston University, UK

11:35 Discussion

11:40 Microbiological investigations for chikungunya virus in children with acute encephalitis syndrome in a non-outbreak setting in Southern India

Ms Maria Jose, National Institute of Mental Health and Neurosciences(NIMHANS), Bengaluru, Karnataka, India

11:50 Discussion

11:55 Investigating T cell immunity in anti-NMDA receptor encephalitis

Dr Rachel Brown, University College London, UK

12:05 Discussion

12:10 Clinical outcomes of adults with suspected encephalitis and meningitis in a high HIV prevalence setting, Blantyre, Malawi

Dr Lerato Mambulu, Kamuzu Central Hospital, Malawi

12:20 Discussion

12:25 INVITED GUEST LECTURE 1

Brains on Fire: Patient Outcomes and Quality of Life Following Encephalitis

Dr Ava Easton, Encephalitis International &University of Liverpool

12:50 Discussion

12:55 LUNCH

Session 3

Chairs: Dr Matteo Gastaldi, Neuroimmunology Research Unit & Diagnostic Laboratory, Pavia, Italy. Assoc Prof Kiran Thakur, Columbia University Irving Medical Center, USA

14:10 KEYNOTE LECTURE 2

Metagenomics, Encephalitis and Global Health

Prof Michael Wilson, UCSF Weill Institute for Neurosciences; Director, UCSF Center for Encephalitis and Meningitis, San Francisco, USA

14:35 Discussion

14:40 Money talks: the cost of encephalitis

Dr Thomas Agerbo Gaist, Odense University Hospital, Denmark

14:50 Discussion

14:55:  Encephalitis International Seed Funding

Differentiating viral encephalitis from its mimics in patients with encephalitis of unknown aetiology

Dr John Kasibante, Makerere University, Kampala, Uganda

Validation of the Pediatric Autoimmune Encephalitis Severity Score (PASS) in children with autoimmune encephalitis

Assoc Prof Priyanka Madaan Amrita Institute of Medical Sciences, Faridabad Haryana, India

15:10 Discussion

15:15 BREAK

Session 4:

Chairs: Dr Ava Easton, Encephalitis International & University of Liverpool, UK. Prof Benedict Michael, University of Liverpool & The Walton Center, Liverpool, UK

15:45 Initial findings of the SAPIENCE project: insights from caregivers

Dr Ole Jonas Boeken, Charite – Universitatsmedizin Berlin, Germany

15:55 Discussion

16:00 DEBATE

Encephalitis Research Fails to Improve Diagnosis and Treatment in Low-to-Middle Income Countries (LMIC)

Chair: Assoc Prof Deanna Saylor, Johns Hopkins University School of Medicine, USA & University Teaching Hospital and the University of Zambia School of Medicine, Lusaka, Zambia

Dr Mashina Chomba, University Teaching Hospital – Adult Hospital, Lusaka, Zambia

Prof Gagandeep Singh, Dayanand Medical College Ludhiana, India

16:30 INVITED GUEST LECTURE 2

Improving Diagnosis and Management of People with Brain Infections in Brazil, India and Malawi

Dr Bhagteshwar Singh, University of Liverpool & Royal Liverpool University Hospital, UK

16:55 Discussion

17:00 Encephalitis International: Our Year

Phillippa Chapman, Encephalitis International

17:05 Awards and call to action

Dr Nicholas Davies, Chair Advisory Scientific Panel, Encephalitis International. Dr Ava Easton, CEO Encephalitis International

17:15 DRINKS AND NETWORKING RECEPTION

Page Created: 8 October 2024
Last Modified: 24 October 2024
Main Menu